Holdings
台灣浩鼎生技股份有限公司
As of Sep 30, 2026, 台灣浩鼎生技股份有限公司 reported 2 positions. Largest: Obigen Pharma, Inc., Ap Biosciences, Inc. and Ap Biosciences, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Obigen Pharma, Inc. | 53M | no change | Sep 30, 2026 | |
| Ap Biosciences, Inc. | 23.2M | no change | Sep 30, 2026 | |
| Ap Biosciences, Inc. | no change | Oct 17, 2026 |